{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T09:18:19Z","timestamp":1768987099170,"version":"3.49.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,7,13]],"date-time":"2018-07-13T00:00:00Z","timestamp":1531440000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Parasites Vectors"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13071-018-2969-3","type":"journal-article","created":{"date-parts":[[2018,7,12]],"date-time":"2018-07-12T08:26:27Z","timestamp":1531383987000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Safety of lotilaner flavoured chewable tablets (CredelioTM) after oral administration in cats"],"prefix":"10.1186","volume":"11","author":[{"given":"Emmanuelle A.","family":"Kuntz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Srinivas","family":"Kammanadiminti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,7,13]]},"reference":[{"key":"2969_CR1","first-page":"521","volume-title":"Veterin\u00e4rmedizinische Parasitologie","author":"K Pfister","year":"2006","unstructured":"Pfister K. In: Schnieder T, editor. Veterin\u00e4rmedizinische Parasitologie. Parey: Stuttgart: Arthropodenbefall bei Hund und Katze; 2006. p. 521\u201359."},{"key":"2969_CR2","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.vetpar.2011.03.040","volume":"179","author":"B Chomel","year":"2011","unstructured":"Chomel B. Tick-borne infections in dogs - an emerging infectious threat. Vet Parasitol. 2011;179:294\u2013301.","journal-title":"Vet Parasitol."},{"key":"2969_CR3","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1186\/s13071-017-2471-3","volume":"10","author":"SE Little","year":"2017","unstructured":"Little SE. Lotilaner - a novel systemic tick and flea control product for dogs. Parasit Vectors. 2017;10:539.","journal-title":"Parasit Vectors."},{"key":"2969_CR4","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1021\/tx400055p","volume":"26","author":"P Garcia-Reynaga","year":"2013","unstructured":"Garcia-Reynaga P, Zhao C, Sarpong R, Casida JE. New GABA\/glutamate receptor target for [(3)H]isoxazoline insecticide. Chem Res Toxicol. 2013;26:514\u20136.","journal-title":"Chem Res Toxicol."},{"key":"2969_CR5","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.ibmb.2013.11.009","volume":"45","author":"M Gassel","year":"2014","unstructured":"Gassel M, Wolf C, Noack S, Williams H, Ilg T. The novel isoxazoline ectoparasiticide fluralaner: selective inhibition of arthropod \u03b3-aminobutyric acid- and L-glutamate-gated chloride channels and insecticidal\/acaricidal activity. Insect Biochem Mol Biol. 2014;45:111\u201324.","journal-title":"Insect Biochem Mol Biol."},{"key":"2969_CR6","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1016\/j.bbrc.2009.11.131","volume":"391","author":"Y Ozoe","year":"2010","unstructured":"Ozoe Y, Asahi M, Ozoe F, Nakahira K, Mita T. The antiparasitic isoxazoline A1443 is a potent blocker of insect ligand-gated chloride channels. Biochem Biophys Res Commun. 2010;391:744\u20139.","journal-title":"Biochem Biophys Res Commun."},{"key":"2969_CR7","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1186\/s13071-017-2477-x","volume":"10","author":"D Cavalleri","year":"2017","unstructured":"Cavalleri D, Murphy M, Gorbea RL, Seewald W, Drake J, Nanchen S. Laboratory evaluations of the immediate and sustained effectiveness of lotilaner (Credelio\u2122) against three common species of ticks affecting dogs in Europe. Parasit Vectors. 2017;10:527.","journal-title":"Parasit Vectors."},{"key":"2969_CR8","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1186\/s13071-017-2474-0","volume":"10","author":"D Cavalleri","year":"2017","unstructured":"Cavalleri D, Murphy M, Seewald W, Drake J, Nanchen S. Assessment of the onset of lotilaner (Credelio\u2122) speed of kill of fleas on dogs. Parasit Vectors. 2017;10:521.","journal-title":"Parasit Vectors."},{"key":"2969_CR9","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1186\/s13071-017-2479-8","volume":"10","author":"D Cavalleri","year":"2017","unstructured":"Cavalleri D, Murphy M, Seewald W, Drake J, Nanchen S. A randomised, blinded, controlled field study to assess the efficacy and safety of lotilaner tablets (Credelio\u2122) in controlling fleas in client-owned dogs in European countries. Parasit Vectors. 2017;10:526.","journal-title":"Parasit Vectors."},{"key":"2969_CR10","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1186\/s13071-017-2478-9","volume":"10","author":"D Cavalleri","year":"2017","unstructured":"Cavalleri D, Murphy M, Seewald W, Drake J, Nanchen S. A randomized, controlled study to assess the efficacy and safety of lotilaner (Credelio\u2122) in controlling ticks in client-owned dogs in Europe. Parasit Vectors. 2017;10:531.","journal-title":"Parasit Vectors."},{"key":"2969_CR11","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1186\/s13071-017-2466-0","volume":"10","author":"D Cavalleri","year":"2017","unstructured":"Cavalleri D, Murphy M, Seewald W, Drake J, Nanchen S. Assessment of the speed of flea kill of lotilaner (Credelio\u2122) throughout the month following oral administration to dogs. Parasit Vectors. 2017;10:529.","journal-title":"Parasit Vectors."},{"key":"2969_CR12","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1186\/s13071-017-2469-x","volume":"10","author":"D Karadzovska","year":"2017","unstructured":"Karadzovska D, Chappell K, Coble S, Murphy M, Cavalleri D, Wiseman S, et al. A randomized, controlled field study to assess the efficacy and safety of lotilaner flavored chewable tablets (Credelio\u2122) in eliminating fleas in client-owned dogs in the USA. Parasit Vectors. 2017;10:528.","journal-title":"Parasit Vectors."},{"key":"2969_CR13","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1186\/s13071-017-2467-z","volume":"10","author":"M Murphy","year":"2017","unstructured":"Murphy M, Cavalleri D, Seewald W, Drake J, Nanchen S. Laboratory evaluation of the speed of kill of lotilaner (Credelio\u2122) against Ixodes ricinus ticks on dogs. Parasit Vectors. 2017;10:541.","journal-title":"Parasit Vectors."},{"key":"2969_CR14","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1186\/s13071-017-2476-y","volume":"10","author":"M Murphy","year":"2017","unstructured":"Murphy M, Garcia R, Karadzovska D, Cavalleri D, Snyder D, Seewald W, et al. Laboratory evaluations of the immediate and sustained efficacy of lotilaner (Credelio\u2122) against four common species of ticks affecting dogs in North America. Parasit Vectors. 2017;10:523.","journal-title":"Parasit Vectors."},{"key":"2969_CR15","doi-asserted-by":"crossref","unstructured":"Toutain CE, Seewald W, Jung M. Pharmacokinetics of lotilaner following a single oral or intravenous administration in cats. Parasit Vectors. 2018 (In press).","DOI":"10.1186\/s13071-018-2966-6"},{"key":"2969_CR16","doi-asserted-by":"crossref","unstructured":"Cavalleri D, Murphy M, Seewald W, Drake J, Nanchen S. A randomized, controlled field study to assess the efficacy and safety of lotilaner (Credelio\u2122) in controlling fleas in client-owned cats in Europe. Parasit Vectors. 2018 (In press).","DOI":"10.1186\/s13071-018-2971-9"},{"key":"2969_CR17","doi-asserted-by":"crossref","unstructured":"Cavalleri D, Murphy M, Seewald W, Drake J, Nanchen S. Laboratory evaluation of the efficacy and speed of kill of lotilaner (Credelio\u2122) against Ixodes ricinus ticks on cats. Parasit Vectors. 2018 (In press).","DOI":"10.1186\/s13071-018-2968-4"},{"key":"2969_CR18","doi-asserted-by":"crossref","unstructured":"Cavalleri D, Murphy M, Seewald W, Nanchen S. A randomized, controlled field study to assess the efficacy and safety of lotilaner (Credelio\u2122) in controlling ticks in client-owned cats in Europe. Parasit Vectors. 2018 (In press).","DOI":"10.1186\/s13071-018-2967-5"},{"key":"2969_CR19","unstructured":"VICH GL 43: Guideline on target animal safety for veterinary pharmaceutical products. Belgium;2008.\n                    http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Scientific_guideline\/2009\/10\/WC500004361.pdf\n                    \n                  . Accessed 12 Feb 2017."},{"key":"2969_CR20","unstructured":"United States Food and Drug Administration. Good laboratory practices (GLP) for non-clinical laboratory studies 21 CFR Part 58. 2016. \n                    https:\/\/www.gpo.gov\/fdsys\/pkg\/CFR-2011-title21-vol1\/pdf\/CFR-2011-title21-vol1-part58.pdf\n                    \n                  . Accessed 12 Feb 2017."},{"key":"2969_CR21","unstructured":"OECD series on principles of good laboratory practice (GLP) and compliance monitoring. 1998. \n                    http:\/\/www.oecd.org\/chemicalsafety\/testing\/oecdseriesonprinciplesofgoodlaboratorypracticeglpandcompliancemonitoring.htm\n                    \n                  . Accessed 12 Feb 2017."},{"key":"2969_CR22","doi-asserted-by":"publisher","first-page":"94","DOI":"10.4103\/0976-500X.72351","volume":"1","author":"C Kilkenny","year":"2010","unstructured":"Kilkenny C, Browne WJ, Cuthill IC, Emerson M, Altman DG. Improving bioscience research reporting: The ARRIVE guidelines for reporting animal research. J Pharmacol Pharmacother. 2010;1:94\u20139.","journal-title":"J Pharmacol Pharmacother"},{"key":"2969_CR23","volume-title":"Statistical Methods","author":"GW Snedecor","year":"1989","unstructured":"Snedecor GW, Cochran WG. Statistical Methods. 8th ed. Ames (IA): Iowa State Press; 1989.","edition":"8"},{"key":"2969_CR24","volume-title":"Analysis of Messy Data Volume III: Analysis of Covariance","author":"GA Milliken","year":"2002","unstructured":"Milliken GA, Johnson DE. Analysis of Messy Data Volume III: Analysis of Covariance. London: Chapman and Hall; 2002."},{"key":"2969_CR25","first-page":"62","volume-title":"Manual of Canine and Feline Cardiology","author":"L Tilley","year":"2008","unstructured":"Tilley L, Smith F, Oyama M, Sleeper M. Manual of Canine and Feline Cardiology. 4th ed. Philadephia, USA: Saunders; 2008. p. 62\u20133.","edition":"4"}],"container-title":["Parasites & Vectors"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-018-2969-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13071-018-2969-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-018-2969-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,12]],"date-time":"2019-07-12T19:17:53Z","timestamp":1562959073000},"score":1,"resource":{"primary":{"URL":"https:\/\/parasitesandvectors.biomedcentral.com\/articles\/10.1186\/s13071-018-2969-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,13]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["2969"],"URL":"https:\/\/doi.org\/10.1186\/s13071-018-2969-3","relation":{},"ISSN":["1756-3305"],"issn-type":[{"value":"1756-3305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,13]]},"assertion":[{"value":"8 March 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was based on the guidelines for evaluating the target animal safety of new pharmaceuticals (VICH Guideline 43), and to recognized quality assurance standards (United States Food and Drug Administration (FDA) Good Laboratory Practice (GLP) Regulations, 21 Code of Federal Regulations (CFR) Part 58 and the Organization for Economic Cooperation and Development (OECD) Series on Principles of Good Laboratory Practice and Compliance Monitoring, Number 13) [\u2013]. The study protocol was reviewed and approved by the study site Ethics Committee (MPI Research, Institutional Animal Care & Use Committee, No 382-218, 02 January 2015) and the sponsor company\u2019s Institutional Animal Care and Use Committee. This manuscript was prepared in compliance with the ARRIVE Guidelines Checklist for animal in vivo experiments [].","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"EAK and SK are employees of Elanco Animal Health.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"409"}}